Microbiome study in Korean patients with ankylosing spondylitis
Part of Bones, joints & muscles clinical trials.
This study looks at the bacteria living in your body (the microbiome) in people with ankylosing spondylitis and their close family members. Researchers hope to better understand how these bacteria relate to the disease, which may lead to better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ankylosing spondylitis.
- You are between 19 and 60 years old.
- You have not taken any antibiotics (pills or shots) in the last 3 months.
- You have not taken any probiotic supplements or lactic acid bacteria supplements in the last 3 months.
- You are willing to provide samples and follow the study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with ankylosing spondylitis (a type of arthritis that affects the spine) who are otherwise healthy. It may test a treatment to see if it helps control symptoms, whether your disease is active or stable.
This study is looking at how well secukinumab works for people with ankylosing spondylitis in Korea who have never taken a biologic or JAK inhibitor before. It aims to understand if the drug helps control symptoms over a short period of time.
This study looks at how a gluten-free diet affects people with ankylosing spondylitis (a type of arthritis that mainly affects the spine). You would eat no gluten (found in wheat, barley, and rye) for a period of time to see if it helps reduce symptoms.
This study is looking for people with ankylosing spondylitis, rheumatoid arthritis, or lupus to help find biomarkers that may make diagnosis easier. If you have one of these conditions and haven't tried biologic therapies, you may be able to join.
This study looks at a specific enzyme (15-hydroxyprostaglandin dehydrogenase) in people with osteoarthritis or ankylosing spondylitis. It may help researchers understand these conditions better and find new treatment targets.
This trial tests whether stem cells from donated bone marrow can reduce inflammation and pain in ankylosing spondylitis, a condition that causes the spine to become stiff and inflamed. Researchers will monitor how safe and effective this treatment is for eligible patients.
Hear when a new Ankylosing Spondylitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.